Given the substantial recent history of including IDH-mutant disease in the umbrella of GBM as well as the uncertainty regarding IDH1 status’s impact, our paper additionally incorporates both IDH-wildtype GBM and IDH-mutant grade IV astrocytomas. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).